Zhiyuan Wu, PhD, is an Associate Professor in the Department of Laboratory Medicine at Huashan Hospital, Fudan University, Shanghai, China. He received his PhD in Laboratory Medicine from Fudan University in 2019. His international research experience includes visiting research at the University of Pittsburgh, and postdoctoral training at Tulane University, and Harvard Medical School’s Global Clinical Scholars Research Training program.

Dr. Wu’s research focuses on molecular diagnostics and translational research on infectious disease and cancer, particularly in liquid biopsy for disease progression and treatment response. His work investigates exosome and cell-free DNA marker for personalized tuberculosis diagnostics and progression prediction, and cancer transformation in myeloproliferative neoplasms, with the aim of translating molecular findings into clinically useful laboratory tests.

He has led three projects funded by the National Natural Science Foundation of China and published research in journals including the Journal of Hematology & Oncology, Theranostics, and Epigenomics.